These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cyclooxygenase-2 as a target for prevention of colorectal cancer. Bertagnolli MM Curr Oncol Rep; 1999; 1(2):173-8. PubMed ID: 11122816 [TBL] [Abstract][Full Text] [Related]
3. COX-2 in large bowel cancer: a one-sided story. DuBOIS RN Gut; 1999 Nov; 45(5):636-7. PubMed ID: 10517891 [No Abstract] [Full Text] [Related]
4. [COX-1 and COX-2: functions and pharmacological effects]. Hinz B; Brune K Pharm Unserer Zeit; 1999 Jan; 28(1):21-9. PubMed ID: 10078026 [No Abstract] [Full Text] [Related]
5. New paradigms for cancer prevention. DuBois RN Carcinogenesis; 2001 May; 22(5):691-2. PubMed ID: 11323385 [No Abstract] [Full Text] [Related]
6. Role of cyclooxygenase inhibitors for the prevention of colorectal cancer. Stack E; DuBois RN Gastroenterol Clin North Am; 2001 Dec; 30(4):1001-10. PubMed ID: 11764529 [TBL] [Abstract][Full Text] [Related]
7. [New anti-inflammatory analgetics--are they needed?]. Paakkari I Duodecim; 1999; 115(20):2217-24. PubMed ID: 11973925 [No Abstract] [Full Text] [Related]
8. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors]. Tishler M; Langevetiz P; Nesher G Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601 [No Abstract] [Full Text] [Related]
9. Growth regulation of Gardner's syndrome colorectal cancer cells by NSAIDs. Hughes-Fulford M; Boman B Adv Exp Med Biol; 1997; 407():433-41. PubMed ID: 9321987 [No Abstract] [Full Text] [Related]
10. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma]. Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057 [TBL] [Abstract][Full Text] [Related]
11. COX-1, COX-2: so what? Emery P Scand J Rheumatol; 1999; 28(1):6-9. PubMed ID: 10092158 [TBL] [Abstract][Full Text] [Related]
12. [Cyclooxygenases, structure, biological functions and the role in inflammation processes]. Kotyla PJ; SliwiĆska-Kotyla B; Kucharz EJ Pol Arch Med Wewn; 2001 Oct; 106(4):963-6. PubMed ID: 11993417 [No Abstract] [Full Text] [Related]
13. [Cyclooxygenase 2 inhibitors and cancer chemoprevention]. Masmoudi A; Chevalier TL; Sabatier L; Soria JC Bull Cancer; 2004 May; 91 Suppl 2():S77-84. PubMed ID: 15899630 [TBL] [Abstract][Full Text] [Related]
14. NSAIDs to prevent colorectal cancer: a question of sensitivity. Elder DJ; Paraskeva C Gastroenterology; 1997 Dec; 113(6):1999-2003. PubMed ID: 9394741 [No Abstract] [Full Text] [Related]
15. Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Feldman M; McMahon AT Ann Intern Med; 2000 Jan; 132(2):134-43. PubMed ID: 10644275 [No Abstract] [Full Text] [Related]
16. COX-2 inhibitors and breast cancer. Singh Ranger G; Mokbel K ANZ J Surg; 2003 Aug; 73(8):565-6. PubMed ID: 12887516 [No Abstract] [Full Text] [Related]